Related Experiment Videos
Effect of exercise on propranolol pharmacokinetics
S Frank1, S M Somani, M Kohnle
1Department of Medicine, Southern Illinois University School of Medicine, Springfield.
European Journal of Clinical Pharmacology
|January 1, 1990
Summary
Submaximal exercise significantly impacts how the body processes low-dose intravenous propranolol, a beta-blocker. Exercise effects are notable but vary greatly between individuals, potentially requiring dose adjustments for patients.
Area of Science:
- Pharmacology
- Exercise Physiology
- Cardiovascular Medicine
Background:
- Propranolol is a commonly prescribed beta-blocker for various cardiovascular conditions.
- Understanding drug pharmacokinetics during physical activity is crucial for patient management.
- Exercise can alter physiological parameters affecting drug absorption, distribution, metabolism, and excretion.
Purpose of the Study:
- To investigate the pharmacokinetic effects of submaximal exercise on low-dose intravenous propranolol in healthy subjects.
- To determine the variability of these effects among individuals.
Main Methods:
- 15 healthy human subjects participated in the study.
- Pharmacokinetic parameters of intravenous propranolol were assessed before and during submaximal exercise.
- Individual responses to exercise were analyzed.
Main Results:
- Submaximal exercise markedly affected propranolol pharmacokinetics.
- A wide range of individual variations in pharmacokinetic changes was observed.
- The degree of exercise-induced changes in drug processing differed significantly across subjects.
Conclusions:
- Exercise exerts a significant but variable influence on propranolol pharmacokinetics.
- Intermittent exercise in patients regularly taking propranolol may necessitate medication dose adjustments.
- Clinical practice should consider the impact of physical activity on propranolol therapy.